Brown Advisory’s BeOne Medicines Ltd ONC Stock Holding History

Brown Advisory’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,287	Closed	-$1.49M	–	1291
2019 Q1	$1.49M	Buy	+11,287	New	+$1.52M	﹤0.01%	715
2018 Q2	–	Sell	-155,022	Closed	-$26M	–	1330
2018 Q1	$26M	Sell	155,022 -140,052	-47%	-$19M	0.08%	201
2017 Q4	$28.8M	Sell	295,074 -38,625	-12%	-$3.54M	0.09%	189
2017 Q3	$34.5M	Sell	333,699 -148,003	-31%	-$11M	0.11%	166
2017 Q2	$21.7M	Buy	481,702 +2,351	+0.5%	+$92.6K	0.07%	216
2017 Q1	$17.5M	Buy	479,351 +21,960	+5%	+$800K	0.06%	236
2016 Q4	$13.9M	Buy	457,391 +106,043	+30%	+$3.33M	0.05%	252
2016 Q3	$10.8M	Buy	351,348 +238,604	+212%	+$6.93M	0.04%	277
2016 Q2	$3.36M	Buy	112,744 +13,092	+13%	+$384K	0.01%	416
2016 Q1	$2.92M	Buy	+99,652	New	+$2.82M	0.01%	421

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Brown Advisory's ONC Position: Q2 2019 in Review

Brown Advisory sold out of BeOne Medicines Ltd (ONC) in Q2 2019, closing a stake of 11,287 shares — an estimated $1.49M sold.

Brown Advisory first reported a position in ONC in Q1 2016 and held it in 10 quarters. The position peaked at $34.5M in Q3 2017. 203 funds tracked by Wall St. Rank hold ONC as of Q2 2019.

Brown Advisory reported no remaining BeOne Medicines Ltd position as of Q2 2019 after selling out during the quarter.
Brown Advisory sold 11,287 BeOne Medicines Ltd shares in Q2 2019, an estimated $1.49M.
Brown Advisory first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 10 quarters.
Brown Advisory's BeOne Medicines Ltd position peaked at $34.5M in Q3 2017.
203 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2019.

Based on Brown Advisory's 13F filing for Q2 2019, filed 12 Aug 2019.